Cell-Free DNA BCT^®

For In Vitro Diagnostic Use

Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing liquid biopsy assays that have been cleared or approved for use with samples collected in the Cell-Free DNA BCT device.

Performance characteristics of this device have only been established on the Guardant360 CDx assay.

TECHNICAL DOCUMENTS | PATENTS

Stabilization Products

Streck’s patented portfolio of stabilization solutions enables scientists to mitigate and limit pre-analytical variation in critical samples, ease handling concerns and allow for room temperature storage, cold-chain free shipping and batch processing. Our direct draw blood collection tubes and preservation products for biofluids are recognized worldwide. Target analytes include cell-free DNA, cell-free RNA, clusters of differentiation antigens, extracellular vesicles and cellular nucleic acids.

View all